This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Spectrazyme (2013-10-11)

Starting date:
October 11, 2013
Posting date:
October 21, 2013
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-36329

Recalled Products

Spectrazyme 

Reason

Voluntary recall initiated due to possible contamination. The product may contain the drug ingredient chloramphenicol.

Depth of distribution

Healthcare practitioners – British Columbia, Ontario, Alberta, Newfoundland and Labrador, Quebec

Affected products

Spectrazyme 

DIN, NPN, DIN-HIM
NPN 80044751
Dosage form

Tablet

Strength
  • Protease (10,000 PC)
  • Papain (100,000 USP)
  • Protease (20,000 HUT)
  • Amylase (10,000 DU)
  • Lipase (1,000 LU)
  • Cellulase (1,000 CU)
  • Peptidase (300 units)
  • Maltase (300 DP)
  • Lactase (200 Lac U)
  • Invertase (200 Summer)
  • Amla (Phylianthus emblica) (20mg)
Lot or serial number
  • 0413083
Companies
Recalling Firm
Metagenics Canada
851 Rangeview Road
Mississauga
L5E 1H1
Ontario
CANADA
Marketing Authorization Holder
Metagenics Canada
851 Rangeview Road
Mississauga
L5E 1H1
Ontario
CANADA

Date modified: